122 related articles for article (PubMed ID: 37394639)
21. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
[TBL] [Abstract][Full Text] [Related]
22. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
[TBL] [Abstract][Full Text] [Related]
23. A novel hypoxia-stimulated lncRNA HIF1A-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.
Xie W; Wang W; Meng S; Wu X; Liu X; Liu Y; Kang X; Su Y; Lv X; Guo L; Wang C
Mol Carcinog; 2023 Dec; 62(12):1860-1876. PubMed ID: 37589417
[TBL] [Abstract][Full Text] [Related]
24. SPOCK2 Promotes the Malignant Behavior of Ovarian Cancer via Regulation of the Wnt/
Zhao S; Liu H; Fan M
Biomed Res Int; 2022; 2022():9223954. PubMed ID: 36193300
[TBL] [Abstract][Full Text] [Related]
25. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
[TBL] [Abstract][Full Text] [Related]
26. Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.
Yu Z; Ouyang L
Hum Cell; 2022 Nov; 35(6):1824-1837. PubMed ID: 35964260
[TBL] [Abstract][Full Text] [Related]
27. The effects of miR-140-5p on the biological characteristics of ovarian cancer cells through the Wnt signaling pathway.
Wu Y; Li J; Chen S; Yu Z
Adv Clin Exp Med; 2020 Jul; 29(7):777-784. PubMed ID: 32750755
[TBL] [Abstract][Full Text] [Related]
28. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
29. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway.
Wang G; Li L; Li Y; Zhang LH
Phytomedicine; 2023 Jan; 109():154571. PubMed ID: 36610147
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
31. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Liu H; Shi H; Fan Q; Sun X
Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway.
Tian H; Hou L; Xiong Y; Cheng Q
Cell Cycle; 2021 Apr; 20(8):765-780. PubMed ID: 33818283
[TBL] [Abstract][Full Text] [Related]
33. Astrocyte elevated gene-1 promotes the proliferation and invasion of breast cancer cells by activating the Wnt/β-catenin signaling pathway.
Li M; Dai Y; Wang L; Li L
Oncol Lett; 2017 Apr; 13(4):2385-2390. PubMed ID: 28454408
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
35. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
37. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
Li D; Zhang Z
Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
[TBL] [Abstract][Full Text] [Related]
38. CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway.
Gao LN; Hao M; Liu XH; Zhang L; Dong Y; Zhang YF; He XC
J Ovarian Res; 2021 Nov; 14(1):159. PubMed ID: 34789307
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of long non-coding RNA PEG10 inhibits growth, migration and invasion of gastric carcinoma cells via up-regulating miR-3200.
Wang J; Chu XQ; Zhang D; Kong DF
Neoplasma; 2018 Sep; 65(5):769-778. PubMed ID: 29940767
[TBL] [Abstract][Full Text] [Related]
40. Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathways.
Meng Y; Hu J; Chen Y; Yu T; Hu L
Oncol Rep; 2016 Nov; 36(5):2463-2470. PubMed ID: 27633480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
